The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is an obesity-associated spectrum of comorbidities defined by the presence of metabolic dysfunction, oxidative stress, inflammation, and fibrosis in the liver. If left untreated, NAFLD can progress to cirrhosis, liver failure, or hepatocellular carcinoma. NA...

Full description

Bibliographic Details
Main Authors: Ana Gabriela Murillo, Diana M. DiMarco, Maria Luz Fernandez
Format: Article
Language:English
Published: MDPI AG 2016-11-01
Series:Biology
Subjects:
Online Access:http://www.mdpi.com/2079-7737/5/4/42
_version_ 1797711901804724224
author Ana Gabriela Murillo
Diana M. DiMarco
Maria Luz Fernandez
author_facet Ana Gabriela Murillo
Diana M. DiMarco
Maria Luz Fernandez
author_sort Ana Gabriela Murillo
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is an obesity-associated spectrum of comorbidities defined by the presence of metabolic dysfunction, oxidative stress, inflammation, and fibrosis in the liver. If left untreated, NAFLD can progress to cirrhosis, liver failure, or hepatocellular carcinoma. NAFLD is recognized as the most common liver disease in the United States, affecting around 30% of the population. Identification of dietary components capable of reducing or preventing NAFLD is therefore essential to battle this condition. Dietary carotenoids including astaxanthin, lycopene, lutein, and zeaxanthin have been demonstrated to be potent antioxidants as well as to exhibit anti-inflammatory effects. Many studies report the protective effect(s) of these carotenoids against different conditions such as atherosclerosis, diabetic complications, age-related macular degeneration, and liver diseases. In this review, we will focus on the effects of these carotenoids in the prevention or reduction of NAFLD as seen in epidemiological observations and clinical trials, as well as the suggested mechanism of action derived from animal and cell studies.
first_indexed 2024-03-12T07:13:49Z
format Article
id doaj.art-158aa3733e6240768a502113fdd23cb2
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-12T07:13:49Z
publishDate 2016-11-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-158aa3733e6240768a502113fdd23cb22023-09-02T22:55:24ZengMDPI AGBiology2079-77372016-11-01544210.3390/biology5040042biology5040042The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver DiseaseAna Gabriela Murillo0Diana M. DiMarco1Maria Luz Fernandez2Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USADepartment of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USADepartment of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USANon-alcoholic fatty liver disease (NAFLD) is an obesity-associated spectrum of comorbidities defined by the presence of metabolic dysfunction, oxidative stress, inflammation, and fibrosis in the liver. If left untreated, NAFLD can progress to cirrhosis, liver failure, or hepatocellular carcinoma. NAFLD is recognized as the most common liver disease in the United States, affecting around 30% of the population. Identification of dietary components capable of reducing or preventing NAFLD is therefore essential to battle this condition. Dietary carotenoids including astaxanthin, lycopene, lutein, and zeaxanthin have been demonstrated to be potent antioxidants as well as to exhibit anti-inflammatory effects. Many studies report the protective effect(s) of these carotenoids against different conditions such as atherosclerosis, diabetic complications, age-related macular degeneration, and liver diseases. In this review, we will focus on the effects of these carotenoids in the prevention or reduction of NAFLD as seen in epidemiological observations and clinical trials, as well as the suggested mechanism of action derived from animal and cell studies.http://www.mdpi.com/2079-7737/5/4/42non-alcoholic fatty liver disease (NAFLD)carotenoidslycopeneastaxanthinluteinzeaxanthinhepatic steatosis
spellingShingle Ana Gabriela Murillo
Diana M. DiMarco
Maria Luz Fernandez
The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
Biology
non-alcoholic fatty liver disease (NAFLD)
carotenoids
lycopene
astaxanthin
lutein
zeaxanthin
hepatic steatosis
title The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
title_full The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
title_fullStr The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
title_full_unstemmed The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
title_short The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
title_sort potential of non provitamin a carotenoids for the prevention and treatment of non alcoholic fatty liver disease
topic non-alcoholic fatty liver disease (NAFLD)
carotenoids
lycopene
astaxanthin
lutein
zeaxanthin
hepatic steatosis
url http://www.mdpi.com/2079-7737/5/4/42
work_keys_str_mv AT anagabrielamurillo thepotentialofnonprovitaminacarotenoidsforthepreventionandtreatmentofnonalcoholicfattyliverdisease
AT dianamdimarco thepotentialofnonprovitaminacarotenoidsforthepreventionandtreatmentofnonalcoholicfattyliverdisease
AT marialuzfernandez thepotentialofnonprovitaminacarotenoidsforthepreventionandtreatmentofnonalcoholicfattyliverdisease
AT anagabrielamurillo potentialofnonprovitaminacarotenoidsforthepreventionandtreatmentofnonalcoholicfattyliverdisease
AT dianamdimarco potentialofnonprovitaminacarotenoidsforthepreventionandtreatmentofnonalcoholicfattyliverdisease
AT marialuzfernandez potentialofnonprovitaminacarotenoidsforthepreventionandtreatmentofnonalcoholicfattyliverdisease